Related Experiment Video
Updated: May 22, 2026
08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
[Biomarker for colorectal cancer].
Takeshi Nagasaka1, Yoshiko Mori, Yuzo Umeda
1Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 25, 2012
Summary
Personalized therapy for colorectal cancer (CRC) advances with new biomarkers. A novel genetic classification using microsatellite instability (MSI) and KRAS/BRAF mutations aids tailored treatment strategies for CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Personalized therapy for colorectal cancer (CRC) relies on identifying effective molecular biomarkers.
- Microsatellite instability (MSI) and KRAS/BRAF mutations are key prognostic and predictive markers in CRC.
Purpose of the Study:
- To present updated data on promising biological markers for colorectal cancer.
- To propose a new genetic classification system for CRC based on MSI and KRAS/BRAF mutation status.
Main Methods:
- Review of recent data on MSI and KRAS/BRAF mutations in CRC.
- Development of a 2x3 genetic classification matrix for CRC patients.
Main Results:
- The proposed 2x3 matrix classifies all CRC cases, including Lynch syndrome, into six distinct cells.
- Each cell within the matrix demonstrates unique biological prognostic and/or predictive features.
Conclusions:
- The new genetic classification provides a framework for personalized treatment strategies in colorectal cancer.
- This classification system aids clinicians in tailoring therapies based on individual patient molecular profiles.
Related Concept Videos
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...